Rautio, R., Alpay, K., Sinisalo, M., & Numminen, J.
Treatment of Intracranial Aneurysms Using the New Surpass Evolve Flow Diverter: Safety Outcomes and Six-Month Imaging Follow-Up
78%
Favorable occlusion rate (OKM C-D) at 6 months
| Number of patients | 29 |
| Number of aneurysms | 30 |
| Major morbidity and mortality | 3% (1/30) |
| In-stent stenosis (≥50%) | 3% (1/34) |
Clinical Neuroradiology | 2020
Rautio, R., Alpay, K., Sinisalo, M., & Numminen, J. (2022). Treatment of intracranial aneurysms using the new Surpass Evolve flow diverter: Safety outcomes and six-month imaging follow-up. Journal of neuroradiology = Journal de neuroradiologie, 49(1), 80–86. https://doi.org/10.1016/j.neurad.2021.03.003
Stryker or its affiliated entities own, use, or have applied for the following trademarks or service marks: Stryker, Surpass Evolve. All other trademarks are trademarks of their respective owners or holders.
Information contained herein for use outside the US only.
AP004697 v1.0